Clinical Trial Update: Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

View source ↗

Summary

A completed observational study in the Triveneto region evaluating adjuvant hormonal therapies for hormone-responsive breast cancer in postmenopausal patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Post Menopausal, Breast Cancer | Status: COMPLETED